Introducing the Cubipol Series and DIBMA 6
Revolutionize membrane protein research with the NativeMPTM Platform
Following our recent breakthrough in solving the first structure of the "human" P2X4 membrane protein via cryo-EM, we're excited to introduce more innovations to our NativeMPTM Platform. Our success with hP2X4, a crucial player in synaptic transmission and imflammation, was achieved using our newest copolymer, Sulfo-Cubipol from the Cubipol Copolymer Series.
We are proud to present the complete Cubipol Copolymer Series and DIBMA 6, the latest additions to our Next Generation Copolymers. Developed by our experts with over 10 years of experience, these copolymers combine the best features of classic copolymers like SMA with the advancements of next-gen technologies such as Ultrasolute Amphipol. This expands the screening potential of the NativeMPTM Platform and enhances the solubilization and stabilization of membrane proteins.
Cubipol and DIBMA 6 are part of the NativeMPTM Platform. More functionalization options are coming soon!
With the NativeMPTM Platform, what previously took many years to solve a structure, can now be accomplished in just 2 months! Dive into the features of our new copolymers or schedule a meeting to discover how they can accelerate your research and unlock new possibilities in drug discovery.
➡ Explore Product Features
Following our recent breakthrough in solving the first structure of the "human" P2X4 membrane protein via cryo-EM, we're excited to introduce more innovations to our NativeMPTM Platform. Our success with hP2X4, a crucial player in synaptic transmission and imflammation, was achieved using our newest copolymer, Sulfo-Cubipol from the Cubipol Copolymer Series.
We are proud to present the complete Cubipol Copolymer Series and DIBMA 6, the latest additions to our Next Generation Copolymers. Developed by our experts with over 10 years of experience, these copolymers combine the best features of classic copolymers like SMA with the advancements of next-gen technologies such as Ultrasolute Amphipol. This expands the screening potential of the NativeMPTM Platform and enhances the solubilization and stabilization of membrane proteins.
Cubipol and DIBMA 6 are part of the NativeMPTM Platform. More functionalization options are coming soon!
With the NativeMPTM Platform, what previously took many years to solve a structure, can now be accomplished in just 2 months! Dive into the features of our new copolymers or schedule a meeting to discover how they can accelerate your research and unlock new possibilities in drug discovery.
➡ Explore Product Features
標(biāo)簽：
蛋白純化;膜蛋白;DIBMA
- 原代肝細(xì)胞分離提取的實(shí)驗(yàn)方法、流程與結(jié)果
- 免疫系統(tǒng)的“多面手”-CD14+單核細(xì)胞抗感染和抗腫瘤免疫中的作用
- 細(xì)胞毒性T淋巴細(xì)胞——CD8+T細(xì)胞在抗感染和抗腫瘤免疫中的作用
- Ames試驗(yàn)（細(xì)菌回復(fù)突變?cè)囼?yàn)）常見(jiàn)問(wèn)題與解答
- 免疫系統(tǒng)的“指揮官”——CD4+T細(xì)胞的基本介紹及研究意義
- IPHASE 金黃地鼠懸浮原代肝細(xì)胞助力藥物代謝的研究
- 適應(yīng)性免疫的核心執(zhí)行者——CD3+T細(xì)胞的介紹及研究意義
- 體外ADME研究——藥物Ⅱ相代謝穩(wěn)定性試驗(yàn)研究的常用體外模型工具
- IPHASE精彩亮相BIOCHINA2025易貿(mào)生物產(chǎn)業(yè)展覽
- IPHASE邀您相聚第64屆美國(guó)毒理學(xué)會(huì)年會(huì)SOT 2025
- IPHASE亮相第十四屆藥理學(xué)會(huì)藥物和化學(xué)異物代謝會(huì)議
- IPHASE亮相第十四屆藥物和化學(xué)異物代謝學(xué)術(shù)會(huì)議
- IPHASE助力區(qū)域創(chuàng)新發(fā)展活動(dòng)暨產(chǎn)學(xué)研聯(lián)動(dòng)創(chuàng)新交流會(huì)
- IPHASE課堂第三期：轉(zhuǎn)運(yùn)體研究原理及設(shè)計(jì)
- 北京華創(chuàng)恒達(dá)科技進(jìn)口一批QC-Beads質(zhì)控珠到貨
- 國(guó)內(nèi)首家：IPHASE ABC家族BCRP轉(zhuǎn)運(yùn)體膜囊泡研發(fā)成功
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com